Health
Nanobody could be used as antiviral treatment against COVID-19 – Drug Target Review
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Researchers have identified a small neutralising antibody, a so-called nanobody, that they say has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has the potential to be developed as an antiviral treatment against COVID-19.
The study was c…
-
General18 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General21 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News17 hours agoNorman Dean Lake refused bail for allegedly threatening to kill Prime Minister Anthony Albanese
-
General24 hours agoFirst Nations children’s commissioner must have power to make change: advocates